Auxano Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Auxano Advisors's LLY Position: Q2 2026 in Review
Auxano Advisors increased its Eli Lilly (LLY) stake by 2.4% in Q2 2026, buying an estimated $51.1K and bringing the position to 2,118 shares worth $2.54M. The position accounts for 0.48% of the portfolio, ranked #35.
Auxano Advisors first reported a position in LLY in Q2 2020 and has held it in 24 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Auxano Advisors held 2,118 shares of Eli Lilly worth $2.54M as of Q2 2026.
- Auxano Advisors bought 50 Eli Lilly shares in Q2 2026, an estimated $51.1K.
- Eli Lilly made up 0.48% of Auxano Advisors's portfolio in Q2 2026, its #35 holding.
- Auxano Advisors first reported a position in Eli Lilly in Q2 2020 and has held it in 24 quarters since.
- 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Auxano Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.